Search results
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Benzinga via Yahoo Finance· 2 years agoGenfit SA (NASDAQ: GNFT) has agreed to acquire the Swiss startup Versantis for CHF40 million upfront...
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Benzinga via Yahoo Finance· 11 months agoIpsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT) announced topline data from the Phase 3 ELATIVE...
GENFIT S.A. Unsponsored ADR (GNFT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Zacks via Yahoo Finance· 8 months agoAfter losing some value lately, a hammer chart pattern has been formed for GENFIT S.A. Unsponsored...
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 9 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...
The 7 Best Biotech Stocks to Buy for February 2023
InvestorPlace via Yahoo Finance· 1 year agoWhile unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech stocks to buy offer investors incredible...
Why CymaBay Morphed From Dollar Stock To Biotech Rocket
Investor's Business Daily· 5 months agoCymaBay Therapeutics is sprinting to the finish line with a breakthrough treatment for a serious...
Why Shares of CymaBay Therapeutics Are Soaring Friday
Motley Fool· 11 months agoWhat happened Shares of CymaBay Therapeutics (NASDAQ: CBAY) were up more than 37% as of 11:15 a.m....
Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug
Investor's Business Daily· 11 months agoIntercept Pharmaceuticals said Friday it will restructure itself after the Food and Drug...
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's...
Benzinga via Yahoo Finance· 1 year agoOn Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that...
European VC Invivo readies its latest fund to back new biotechs
BioPharma Dive via Yahoo Finance· 3 months agoThe Barcelona-based firm, which is targeting about 100 million euros for the new fund, is eyeing...